NL7102255A - - Google Patents

Info

Publication number
NL7102255A
NL7102255A NL7102255A NL7102255A NL7102255A NL 7102255 A NL7102255 A NL 7102255A NL 7102255 A NL7102255 A NL 7102255A NL 7102255 A NL7102255 A NL 7102255A NL 7102255 A NL7102255 A NL 7102255A
Authority
NL
Netherlands
Application number
NL7102255A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7102255A publication Critical patent/NL7102255A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126Acids containing more than four carbon atoms
    • C07C53/128Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NL7102255A 1970-02-24 1971-02-19 NL7102255A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707006583A FR2077918B1 (fr) 1970-02-24 1970-02-24

Publications (1)

Publication Number Publication Date
NL7102255A true NL7102255A (fr) 1971-08-26

Family

ID=9051186

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7102255A NL7102255A (fr) 1970-02-24 1971-02-19

Country Status (7)

Country Link
US (1) US3814812A (fr)
BE (1) BE762399A (fr)
DE (1) DE2105925C3 (fr)
ES (1) ES388527A1 (fr)
FR (1) FR2077918B1 (fr)
GB (1) GB1301973A (fr)
NL (1) NL7102255A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301176A (en) * 1980-08-18 1981-11-17 Warner-Lambert Company Method of administering calcium valproate
FR2547499A1 (fr) * 1983-06-15 1984-12-21 Opochimiotherapie Lab Medicaments contenant du dipropylacetate de calcium
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
US5070710A (en) * 1989-02-07 1991-12-10 Sara Lee Corporation Garment blank and method of making it
CA2620333A1 (fr) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenese par modulation du recepteur muscarinique
EP2258358A3 (fr) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenèse avec un inhibiteur de l'acetylcholinestérase
EP1940389A2 (fr) 2005-10-21 2008-07-09 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
CA2625210A1 (fr) 2005-10-31 2007-05-10 Braincells, Inc. Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080188457A1 (en) * 2007-02-02 2008-08-07 Braincells, Inc. Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2266992A (en) * 1939-03-15 1941-12-23 American Cyanamid Co Therapeutic composition

Also Published As

Publication number Publication date
BE762399A (fr) 1971-08-02
DE2105925B2 (de) 1974-04-04
FR2077918A1 (fr) 1971-11-05
ES388527A1 (es) 1974-04-16
DE2105925A1 (fr) 1971-09-09
DE2105925C3 (de) 1974-11-21
GB1301973A (fr) 1973-01-04
FR2077918B1 (fr) 1973-04-06
US3814812A (en) 1974-06-04

Similar Documents

Publication Publication Date Title
FR2077918B1 (fr)
AU2044470A (fr)
AU1473870A (fr)
AU1517670A (fr)
AU2017870A (fr)
AU1716970A (fr)
AU1336970A (fr)
AU1326870A (fr)
AU2085370A (fr)
AU2130570A (fr)
AU1833270A (fr)
AU1943370A (fr)
AU1872870A (fr)
AU1974970A (fr)
AU2130770A (fr)
AU2061170A (fr)
AU1277070A (fr)
AU2112570A (fr)
AU1343870A (fr)
AU1841070A (fr)
AU2115870A (fr)
AU1918570A (fr)
AU1881070A (fr)
AU1879170A (fr)
AU1235770A (fr)